Economic Burden of Checkpoint Inhibitor Immunotherapy for the Treatment of Non–Small Cell Lung Cancer in US Clinical Practice
2020 ◽
Vol 42
(9)
◽
pp. 1682-1698.e7
◽
Mary K. Nesline
◽
Tyler Knight
◽
Sam Colman
◽
Kayshap Patel
2021 ◽
Vol 16
(3)
◽
pp. S520-S521
T. Hakozaki
◽
R. Kitadai
◽
S. Kitagawa
◽
Y. Hosomi
B Gracia
◽
A Murgadella Sancho
◽
L Losa Lopez
◽
A Puebla Villaescusa
◽
E Hidalgo Albert
2021 ◽
Vol 16
(3)
◽
pp. S298
A. Klink
◽
A. Falkenstein
◽
D. Chopra
◽
A. Gajra
2020 ◽
Vol 85
(4)
◽
pp. 761-771
◽
Ou Yamaguchi
◽
Hisao Imai
◽
Hiroyuki Minemura
◽
Kensuke Suzuki
◽
Satoshi Wasamoto
◽
...
2017 ◽
Vol 12
(11)
◽
pp. S2080-S2081
R. Gironés
◽
F. Aparisi
◽
A. Sánchez
◽
J. García
◽
Ó. Juan
2010 ◽
Vol 21
◽
pp. v116-v119
◽
G. D'Addario
◽
M. Früh
◽
M. Reck
◽
P. Baumann
◽
W. Klepetko
◽
...
Malcolm D. Mattes
◽
Timothy D. Eubank
◽
Mohammed Almubarak
◽
Sijin Wen
◽
Gary D. Marano
◽
...
Yinjie Gao
◽
Michelle M. Stein
◽
Prerna Jain
◽
Denise Lau
◽
Kimberly L. Blackwell
◽
...
2018 ◽
Vol Volume 10
◽
pp. 5537-5544
◽
Stefan Diem
◽
Mirjam Fässler
◽
Omar Hasan Ali
◽
Marco Siano
◽
Rebekka Niederer
◽
...